Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels

FASEB Journal

Volumn 28, Issue 12, 2014, Pages 5376-5387

  Elies, Jacobo ^a   Scragg, Jason L ^a   Huang, Sha ^b   Dallas, Mark L ^c   Huang, Dongyang ^b   MacDougall, David ^a   Boyle, John P ^a   Gamper, Nikita ^a,b   Peers, Chris ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL T TYPE; CALCIUM CHANNEL T TYPE CAV3.1; CALCIUM CHANNEL T TYPE CAV3.2; CALCIUM CHANNEL T TYPE CAV3.3; ETHYLENEDIAMINE DERIVATIVE; HYDROGEN SULFIDE; N,N,N',N' TETRA 2 PICOLYLETHYLENEDIAMINE; UNCLASSIFIED DRUG; ZINC; CACNA1H PROTEIN, HUMAN; CALCIUM CHANNEL BLOCKING AGENT;

ANIMAL CELL; ARTICLE; CHELATION; CONTROLLED STUDY; DONOR; HEK293 CELL LINE; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; METAL BINDING; NERVE CELL; NONHUMAN; PATCH CLAMP TECHNIQUE; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; ANIMAL; CELL LINE; DRUG EFFECTS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CELL LINE; HEK293 CELLS; HUMANS; HYDROGEN SULFIDE; PATCH-CLAMP TECHNIQUES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84919775121     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-257113     Document Type: Article

References (64)

1. Szabo, C. (2007) Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6, 917-935
2. Li, L., Rose, P., and Moore, P. K. (2011) Hydrogen sulfide and cell signaling. Annu. Rev. Pharmacol. Toxicol. 51, 169-187
3. Wang, R. (2012) Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol. Rev. 92, 791-896
4. Paul, B. D., and Snyder, S. H. (2012) H2S signalling through protein sulfhydration and beyond. Nat. Rev. Mol. Cell Biol. 13, 499-507
5. Shibuya, N., Mikami, Y., Kimura, Y., Nagahara, N., and Kimura, H. (2009) Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J. Biochem. 146, 623-626
6. Shibuya, N., Tanaka, M., Yoshida, M., Ogasawara, Y., Togawa, T., Ishii, K., and Kimura, H. (2009) 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid. Redox Signal. 11, 703-714
7. Ishigami, M., Hiraki, K., Umemura, K., Ogasawara, Y., Ishii, K., and Kimura, H. (2009) A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid. Redox Signal. 11, 205-214
8. Benavides, G. A., Squadrito, G. L., Mills, R. W., Patel, H. D., Isbell, T. S., Patel, R. P., Darley-Usmar, V. M., Doeller, J. E., and Kraus, D. W. (2007) Hydrogen sulfide mediates the vasoactivity of garlic. Proc. Natl. Acad. Sci. U. S. A. 104, 17977-17982
9. Whiteman, M., Li, L., Kostetski, I., Chu, S. H., Siau, J. L., Bhatia, M., and Moore, P. K. (2006) Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem. Biophys. Res. Commun. 343, 303-310
10. Whiteman, M., Armstrong, J. S., Chu, S. H., Jia-Ling, S., Wong, B. S., Cheung, N. S., Halliwell, B., and Moore, P. K. (2004) The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J. Neurochem. 90, 765-768
11. Kimura, Y., Goto, Y., and Kimura, H. (2010) Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid. Redox Signal. 12, 1-13
12. Gong, Q. H., Shi, X. R., Hong, Z. Y., Pan, L. L., Liu, X. H., and Zhu, Y. Z. (2011) A new hope for neurodegeneration: possible role of hydrogen sulfide. J. Alzheimers Dis. 24(Suppl. 2), 173-182
13. Abe, K., and Kimura, H. (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 16, 1066-1071
14. Kimura, H., Shibuya, N., and Kimura, Y. (2012) Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid. Redox Signal. 17, 45-57
15. Kimura, Y., and Kimura, H. (2004) Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 18, 1165-1167
16. Zhang, Y., Tang, Z. H., Ren, Z., Qu, S. L., Liu, M. H., Liu, L. S., and Jiang, Z. S. (2013) Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases. Mol. Cell. Biol. 33, 1104-1113
17. v 3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain. Pain 150, 183-191
18. Maeda, Y., Aoki, Y., Sekiguchi, F., Matsunami, M., Takahashi, T., Nishikawa, H., and Kawabata, A. (2009) Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels. Pain 142, 127-132
19. Kawabata, A., Ishiki, T., Nagasawa, K., Yoshida, S., Maeda, Y., Takahashi, T., Sekiguchi, F., Wada, T., Ichida, S., and Nishikawa, H. (2007) Hydrogen sulfide as a novel nociceptive messenger. Pain 132, 74-81
20. Calvert, J. W., Jha, S., Gundewar, S., Elrod, J. W., Ramachandran, A., Pattillo, C. B., Kevil, C. G., and Lefer, D. J. (2009) Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ. Res. 105, 365-374
21. Predmore, B. L., and Lefer, D. J. (2011) Hydrogen sulfidemediated myocardial pre- and post-conditioning. Expert Rev. Clin. Pharmacol. 4, 83-96
22. ATP channel opener. EMBO J. 20, 6008-6016
23. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322, 587-590
24. Peers, C., Bauer, C. C., Boyle, J. P., Scragg, J. L., and Dallas, M. L. (2012) Modulation of ion channels by hydrogen sulfide. Antioxid. Redox Signal. 17, 95-105
25. Mustafa, A. K., Sikka, G., Gazi, S. K., Steppan, J., Jung, S. M., Bhunia, A. K., Barodka, V. M., Gazi, F. K., Barrow, R. K., Wang, R., Amzel, L. M., Berkowitz, D. E., and Snyder, S. H. (2011) Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ. Res. 109, 1259-1268
26. 2S signals through protein S-sulfhydration. Sci. Signal. 2, ra72
27. Perez-Reyes, E. (2003) Molecular physiology of low-voltage-activated T-type calcium channels. Physiol. Rev. 83, 117-161
28. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ. Res. 79, 14-19
29. Rodman, D. M., Reese, K., Harral, J., Fouty, B., Wu, S., West, J., Hoedt-Miller, M., Tada, Y., Li, K. X., Cool, C., Fagan, K., and Cribbs, L. (2005) Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes. Circ. Res. 96, 864-872
30. Santoni, G., Santoni, M., and Nabissi, M. (2012) Functional role of T-type calcium channels in tumour growth and progression: prospective in cancer therapy. Br. J. Pharmacol. 166, 1244-1246
31. Talley, E. M., Cribbs, L. L., Lee, J. H., Daud, A., Perez-Reyes, E., and Bayliss, D. A. (1999) Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J. Neurosci. 19, 1895-1911
32. Jevtovic-Todorovic, V., and Todorovic, S. M. (2006) The role of peripheral T-type calcium channels in pain transmission. Cell Calcium 40, 197-203
33. Todorovic, S. M., and Jevtovic-Todorovic, V. (2011) T-type voltage-gated calcium channels as targets for the development of novel pain therapies. Br. J. Pharmacol. 163, 484-495
34. Yang, G. D., and Wang, R. (2007) H2S and cellular proliferation and apoptosis. Sheng Li Xue Bao 59, 133-140
35. 2+ channels reveals tonic modulation by thioredoxin. FASEB J. 27, 3395-3407
36. Claycomb, W. C., Lanson, N. A., Jr., Stallworth, B. S., Egeland, D. B., Delcarpio, J. B., Bahinski, A., and Izzo, N. J., Jr. (1998) HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 95, 2979-2984
37. Kirton, H. M., Pettinger, L., and Gamper, N. (2013) Transient overexpression of genes in neurons using nucleofection. Methods Mol. Biol. 998, 55-64
38. 2+ channels by hypoxia and glutathione. Pflügers Arch. 441, 181-188
39. Nelson, M. T., Woo, J., Kang, H. W., Vitko, I., Barrett, P. Q., Perez-Reyes, E., Lee, J. H., Shin, H. S., and Todorovic, S. M. (2007) Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. J. Neurosci. 27, 8250-8260
40. Nelson, M. T., Joksovic, P. M., Su, P., Kang, H. W., Van, D. A., Baumgart, J. P., David, L. S., Snutch, T. P., Barrett, P. Q., Lee, J. H., Zorumski, C. F., Perez-Reyes, E., and Todorovic, S. M. (2007) Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J. Neurosci. 27, 12577-12583
41. Lee, J. H., Gomora, J. C., Cribbs, L. L., and Perez-Reyes, E. (1999) Nickel block of three cloned T-type calcium channels: low concentrations selectively block α1H. Biophys. J. 77, 3034-3042
42. Kang, H. W., Park, J. Y., Jeong, S. W., Kim, J. A., Moon, H. J., Perez-Reyes, E., and Lee, J. H. (2006) A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels. J. Biol. Chem. 281, 4823-4830
43. Sekiguchi, F., Miyamoto, Y., Kanaoka, D., Ide, H., Yoshida, S., Ohkubo, T., and Kawabata, A. (2014) Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells. Biochem. Biophys. Res. Commun. 445, 225-229
44. Matsunami, M., Kirishi, S., Okui, T., and Kawabata, A. (2011) Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels. Neuroscience 181, 257-264
45. Linley, J. E., Rose, K., Patil, M., Robertson, B., Akopian, A. N., and Gamper, N. (2008) Inhibition of M current in sensory neurons by exogenous proteases: a signaling pathway mediating inflammatory nociception. J. Neurosci. 28, 11240-11249
46. - channels. J. Clin. Invest. 120, 1240-1252
47. 2+ currents in rat cardiac dorsal root ganglion neurons. Brain Res. 961, 171-178
48. Todorovic, S. M., Jevtovic-Todorovic, V., Meyenburg, A., Mennerick, S., Perez-Reyes, E., Romano, C., Olney, J. W., and Zorumski, C. F. (2001) Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron 31, 75-85
49. 2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. J. Neurosci. 25, 8766-8775
50. Kang, H. W., Vitko, I., Lee, S. S., Perez-Reyes, E., and Lee, J. H. (2010) Structural determinants of the high affinity extracellular zinc binding site on Cav3.2 T-type calcium channels. J. Biol. Chem. 285, 3271-3281
51. Perez-Reyes, E., and Lee, J. H. (2014) Ins and outs of T-channel structure function. Pflügers Arch. 466, 627-633
52. Nelson, M. T., Todorovic, S. M., and Perez-Reyes, E. (2006) The role of T-type calcium channels in epilepsy and pain. Curr. Pharm. Des. 12, 2189-2197
53. Swayne, L. A., and Bourinet, E. (2008) Voltage-gated calcium channels in chronic pain: emerging role of alternative splicing. Pflügers Arch. 456, 459-466
54. Jagodic, M. M., Pathirathna, S., Nelson, M. T., Mancuso, S., Joksovic, P. M., Rosenberg, E. R., Bayliss, D. A., Jevtovic-Todorovic, V., and Todorovic, S. M. (2007) Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J. Neurosci. 27, 3305-3316
55. Messinger, R. B., Naik, A. K., Jagodic, M. M., Nelson, M. T., Lee, W. Y., Choe, W. J., Orestes, P., Latham, J. R., Todorovic, S. M., and Jevtovic-Todorovic, V. (2009) In vivo silencing of the CaV3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145, 184-195
56. Jagodic, M. M., Pathirathna, S., Joksovic, P. M., Lee, W., Nelson, M. T., Naik, A. K., Su, P., Jevtovic-Todorovic, V., and Todorovic, S. M. (2008) Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. J. Neurophysiol. 99, 3151-3156
57. Short, G., Lee, M., and Snutch, T. (2014) A first in-class T-type calcium channel blocker effective in nonclinical models of acute and inflammatory pain. J. Pain 14, S71
58. Todorovic, S. M., and Jevtovic-Todorovic, V. (2014) Targeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy. Pflügers Arch. 466, 701-706
59. Streng, T., Axelsson, H. E., Hedlund, P., Andersson, D. A., Jordt, S. E., Bevan, S., Andersson, K. E., Hogestatt, E. D., and Zygmunt, P. M. (2008) Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur. Urol. 53, 391-399
60. Feng, X., Zhou, Y. L., Meng, X., Qi, F. H., Chen, W., Jiang, X., and Xu, G. Y. (2013) Hydrogen sulfide increases excitability through suppression of sustained potassium channel currents of rat trigeminal ganglion neurons. Mol. Pain 9, 4
61. Poulsen, C. B., Al-Mashhadi, R. H., Cribbs, L. L., Skott, O., and Hansen, P. B. (2011) T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles. Kidney Int. 79, 443-451
62. 2+ channels in vascular smooth muscle: multiple functions. Cell Calcium 40, 221-230
63. Dziegielewska, B., Gray, L. S., and Dziegielewski, J. (2014) T-type calcium channels blockers as new tools in cancer therapies. Pflügers Arch. 466, 801-810
64. Kashfi, K., and Olson, K. R. (2013) Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem. Pharmacol. 85, 689-703